These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34815277)

  • 1. Multicentre prospective observational study of sodium-glucose cotransporter-2 inhibitor-associated postoperative ketoacidosis: the SAPKA study protocol.
    Seki H; Kuratani N; Shiga T; Iwasaki Y; Karita K; Yasuda K; Yorozu T
    BMJ Open; 2021 Nov; 11(11):e049592. PubMed ID: 34815277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.
    Qiu H; Novikov A; Vallon V
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28099783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT2 Inhibitors May Predispose to Ketoacidosis.
    Taylor SI; Blau JE; Rother KI
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2849-52. PubMed ID: 26086329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes.
    Horii T; Oikawa Y; Atsuda K; Shimada A
    J Diabetes Investig; 2021 Sep; 12(9):1586-1593. PubMed ID: 33448127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
    Pfützner A; Klonoff D; Heinemann L; Ejskjaer N; Pickup J
    Endocrine; 2017 Apr; 56(1):212-216. PubMed ID: 28303514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
    Menghoum N; Oriot P; Hermans MP; Mariage JL
    Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature.
    Chacko B; Whitley M; Beckmann U; Murray K; Rowley M
    Anaesth Intensive Care; 2018 Mar; 46(2):215-219. PubMed ID: 29519226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition.
    Sanusi I; Sarnowski A; Russell-Jones D; Forni LG
    J Crit Care; 2020 Jun; 57():19-22. PubMed ID: 32007835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.
    Liakos A; Tsapas A; Bekiari E
    Ann Intern Med; 2020 Dec; 173(12):JC70. PubMed ID: 33316195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.
    Perry RJ; Shulman GI
    J Biol Chem; 2020 Oct; 295(42):14379-14390. PubMed ID: 32796035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
    Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
    Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.
    Milder DA; Milder TY; Kam PCA
    Anaesthesia; 2018 Aug; 73(8):1008-1018. PubMed ID: 29529345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
    Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
    Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
    Valek R; Von der Mark J
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):145-148. PubMed ID: 27221094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
    Seger CD; Xing H; Wang L; Shin JS
    A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Renal Failure, Ketoacidosis, and Urogenital Tract Infections with SGLT2 Inhibitors: Signal Detection Using a Japanese Spontaneous Reporting Database.
    Katsuhara Y; Ogawa T
    Clin Drug Investig; 2020 Jul; 40(7):645-652. PubMed ID: 32451843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus.
    Fattah H; Vallon V
    Drugs; 2018 May; 78(7):717-726. PubMed ID: 29663292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative Ketoacidosis under SGLT2-Inhibitors].
    Buck S; Russo SG
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2021 Oct; 56(10):704-708. PubMed ID: 34704247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
    Klinkner G; Steingraber-Pharr M
    AACN Adv Crit Care; 2023 Mar; 34(1):27-32. PubMed ID: 36877649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.